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Abstract ATP represents a major gliotransmitter that
serves as a signaling molecule for the cross talk between
glial and neuronal cells. ATP has been shown to be released
by astrocytes in response to a number of stimuli under
nonischemic conditions. In this study, using a luciferin-
luciferase assay, we found that mouse astrocytes in primary
culture also exhibit massive release of ATP in response to
ischemic stress mimicked by oxygen-glucose deprivation
(OGD). Using a biosensor technique, the local ATP
concentration at the surface of single astrocytes was found
to increase to around 4 μM. The OGD-induced ATP release
was inhibited by Gd
3+ and arachidonic acid but not by
blockers of volume-sensitive outwardly rectifying Cl
−
channels, cystic fibrosis transmembrane conductance regu-
lator (CFTR), multidrug resistance-related protein (MRP),
connexin or pannexin hemichannels, P2X7 receptors, and
exocytotic vesicular transport. In cell-attached patches on
single astrocytes, OGD caused activation of maxi-anion
channels that were sensitive to Gd
3+ and arachidonic acid.
The channel was found to be permeable to ATP
4− with a
permeability ratio of PATP/PCl=0.11. Thus, it is concluded
that ischemic stress induces ATP release from astrocytes
and that the maxi-anion channel may serve as a major ATP-
releasing pathway under ischemic conditions.
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Abbreviations
ATP adenosine 5′-triphosphate
BAPTA-
AM
1,2-bis(o-aminophenoxyl)ethane-N,N,N’,
N’-tetraacetic acid tetra(acetoxymethyl) ester
BFA brefeldin A
CFTR cystic fibrosis transmembrane conductance
regulator
EDTA ethylenediaminetetraacetic acid
EGTA ethylene glycol bis(β-aminoethylether)-N,N,
N’,N’-tetraacetic acid
FBS fetal bovine serum
HEPES N-(2-hydroxyethyl)piperazine-
N’-(2-ethanesulfonic acid)
MDR multidrug resistance protein
MEM minimum essential medium
MRP multidrug resistance-related protein
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VSOR volume-sensitive outwardly rectifying
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Astrocytes do not merely support, but actively regulate,
neuronal functions by forming highly elaborate networks
with other astrocytes and neurons [1–4]. Astrocytes
communicate with neurons by releasing extracellular
signaling molecules such as ATP and glutamate, while they
communicate with each other via gap junctions, in addition
to these gliotransmitters. Astrocytic ATP release has been
shown to be induced in response to receptor stimulation by
UTP [5], glutamate [6], and noradrenaline [7], to mechan-
ical stimulation [8–10], to osmotic swelling [11], and to
exposure to low Ca
2+ solution [8, 9, 12]. Although
ischemic stress is known to induce ATP release from rat
hippocampal slices [13], it is not known whether astrocytes
respond to ischemia with ATP release. The first purpose of
the present study was to address this question.
Astrocytes express maxi-anion channels with a large
single-channel conductance of 200–400 pS [14–16]. Re-
cently, we have demonstrated that astrocytic maxi-anion
channels are activated by chemical ischemia and serve as
one of the major pathways for glutamate release [17]. The
maxi-anion channel was found to possess a pore with a size
large enough to permeate ATP [18] and was found to
actually conduct anionic forms of ATP in mammary C127
cells under hypotonic conditions [19], in kidney macula
densa cells in response to increased luminal NaCl concen-
trations [20], and in cardiac myocytes under hypotonic or
ischemic conditions [21]. Thus, there is a possibility that
maxi-anion channels serve as one of the pathways for ATP
release from astrocytes under ischemic conditions. The
second purpose of this study was to test this possibility.
Materials and methods
Cells
Astrocytes were obtained from neonatal mouse brain cortex
and cultured, as previously described [17, 22], in Eagle’s
MEM supplemented with L-glutamine, 100 U/ml penicillin,
0.1 mg/ml streptomycin, 10% FBS, and 2.2 mg/ml
NaHCO3.
HEK293 cells stably transfected with recombinant P2X2
purinergic receptors were prepared and cultured, as de-
scribed elsewhere [23]. The HEK-P2X2 cells were used
after dissociation into single cells and culturing in suspen-
sion for over 10 min.
Solutions and chemicals
The standard Ringer solution contained (mM): 135 NaCl, 5
KCl, 2 CaCl2, 1 MgCl2, 5 Na-HEPES, 6 HEPES, and 5
glucose (pH 7.4, 290 mosmol/kg H2O). For inside-out
experiments, we used standard Ringer solution both in the
bath and in the pipette. The pipette solution for biosensor
whole-cell experiments contained (mM): 125 CsCl, 2
CaCl2, 1 MgCl2, 10 EGTA, and 5 HEPES (pCa 7.6,
275 mosmol/kg H2O, pH 7.4 adjusted with CsOH). For
ATP conductance measurements in the inside-out configu-
ration, the bath solution was substituted with a solution of
100 mM Na4ATP.
Oxygen-glucose deprivation (OGD) stress was applied
by switching the perfusate from the standard Ringer
solution to the OGD solution. The OGD solution was
prepared by replacing D-glucose in Ringer solution with 2-
deoxyglucose and was continuously bubbled with 100%
argon gas for more than 1 h before and during experiments.
The oxygen concentration (pO2) measured using an oxygen
sensor (LICOX A3R, GMS, Kiel-Mielkendorf, Germany)
was 118.4±1.1 mmHg (n=8) for standard Ringer solution
exposed to air in the experimental perfusion chamber.
Under OGD conditions, the oxygen concentration in the
perfusate solution decreased to a stable value of 7.5±
0.6 mmHg (n=9) at the inlet and 40.1±1.8 mmHg (n=8)at
the outlet of the experimental patch-clamp chamber.
GdCl3 was stored as a 50-mM stock solution in water
and added directly to solutions immediately before each
experiment. Arachidonic acid, phloretin, brefeldin A (BFA),
1-octanol, probenecid, glibenclamide, and apyrase were
purchased from Sigma-Aldrich (St. Louis, MO, USA) and
BAPTA-AM from DOJINDO (Kumamoto, Japan); they
were added to solutions immediately before use from stock
solutions in DMSO. DMSO did not have any effect when
added alone at concentrations employed in the present
study (less than 0.1%).
Osmolality of all solutions was measured using a
freezing-point depression osmometer (OM802, Vogel,
Kevelaer, Germany).
Luciferin-luciferase ATP assay
The bulk extracellular ATP concentration was measured by
a luciferin-luciferase assay (ATP Luminescence Kit; AF-
2L1, DKK-TOA, Tokyo, Japan) with an ATP analyzer (AF-
100, DKK-TOA, Tokyo, Japan), as previously described
[19, 21, 24], using astrocytes cultured in 12- or 24-well
plates. After the culture medium was totally replaced with
isotonic Ringer solution (1,000 and 425 μl for 12- and 24-
well plates, respectively), cells were incubated for 60 min at
37°C. An aliquot (100 μl) of the extracellular solution was
collected as a control sample for background ATP release.
An OGD challenge was then applied by gently removing
most of the remaining extracellular solution (875 and
300 μl for 12- and 24-well plates, respectively) and adding
the OGD solution (1,000 and 400 μl for 12- and 24-well
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airtight incubator where normal air was replaced with 100%
argon. At the specified time points, the plate was carefully
rocked again to ensure homogeneity of the extracellular
solution, and samples (20 and 50 μl for 12- and 24-well
plates, respectively) were collected from each well for the
luminometric ATP assay. The ATP concentration was
measured by mixing 20 or 50 μl of sample solution with
530 or 500 μl normal Ringer solution and 50 μlo f
luciferin-luciferase reagent. At this ratio, the ionic salt
sensitivity of the luciferase reaction was negligible. When
required, drugs were added to the OGD solution to give the
final concentrations as indicated. Since Gd
3+ is known to
interfere with the luciferin-luciferase reaction [25], we
supplemented the luciferin-luciferase assay mixture with
600 μM EDTA when the samples contained Gd
3+. Other
drugs employed in the present study had no significant
effect on the luciferin-luciferase reaction.
Biosensor ATP measurements
To measure the local concentration of ATP released from
single astrocytes, the biosensor technique was employed, as
described previously [23]. ATP-dependent changes in
whole-cell P2X2 receptor currents were recorded from a
biosensor HEK-P2X2 cell at a holding potential of −50 mV.
Before the actual measurements of ATP release, a calibra-
tion curve was constructed by recording the biosensor
responses to known concentrations of ATP. The biosensor
cell in the whole-cell configuration was lifted by means of a
micromanipulator and positioned near a handmade local
microperfusion device consisting of several inlet tubes.
Each of the inlet tubes was filled with a different
concentration of ATP solution ranging from 1 to 20 μM.
To minimize the effect of desensitization, the sensor cell
was exposed to ATP puffed every 3 min for 1 s to a
maximum of five applications. During the measurements of
ATP from an individual astrocyte under OGD stress, the
biosensor cell was gently touched to the surface of the
target cell. From the recorded currents, the concentration of
ATP was calculated according to the calibration curve.
Patch-clamp experiments and data analysis
Patch-clamp experiments were performed, as described
previously [17, 19], using an EPC-9 patch-clamp system
(HEKA Electronics, Lambrecht/Pfalz, Germany). The
membrane potential was controlled by shifting the pipette
potential (Vp). Currents were sampled at 3 kHz and filtered
at 1 kHz. Data acquisition and analysis were done using
Pulse+PulseFit (HEKA Electronics, Lambrecht/Pfalz, Ger-
many). Whenever the bath Cl
− concentration was altered, a
salt bridge containing 3 M KCl in 2% agarose was used to
minimize variations of the bath electrode potential. Liquid
junction potentials were corrected online. All experiments
were performed at room temperature (23–25°C).
Single-channel amplitudes were measured by manually
placing a cursor at the open and closed channel levels.
Background currents were subtracted and the mean patch
currents were measured at the beginning (first 25–30 ms) of
current traces in order to minimize the contribution of
voltage-dependent current inactivation. The reversal poten-
tials were calculated by fitting I–V curves to a second-order
polynomial [18] or measured directly from ramp currents.
Permeability ratios were calculated, as described previously
[19, 21]. Data were analyzed in Origin 6 or 7 (OriginLab
Corporation, Northampton, MA, USA). Pooled data are
given as means ± SEM of n observations.
Statistical differences of the data were evaluated by
analysis of variance (ANOVA) and the paired or unpaired
Student’s t-test where appropriate and were considered
significant at P<0.05.
Results
OGD induces massive release of ATP from astrocytes
Under control conditions, when astrocytes were incubated
in standard Ringer solution, the basal release of ATP was
very low and did not exceed 0.25 nM over 40 min
incubation time (Fig. 1a: open circles). In contrast, when
cells were transferred to OGD conditions, the bulk ATP in
the incubation medium rapidly increased from the basal
level to a peak level of approximately 2 nM within 15–
20 min. After this period, the extracellular ATP concentra-
tion remained high up to 30 min of incubation and then
slightly decreased at 40 min of incubation under OGD
stress (Fig. 1a: filled circles).
In the following pharmacological experiments, we used
an incubation time point of 20 min, when the net ATP
release induced by OGD reached a steady-state level.
Application of extracellular 50 μMG d
3+ nearly completely
inhibited OGD-induced ATP release from cultured mouse
astrocytes. Arachidonic acid (20 μM) also significantly
inhibited OGD-induced ATP release. In contrast, OGD-
induced ATP release was not significantly affected by
blockers of the volume-sensitive outwardly rectifying
(VSOR) Cl
− channel, phloretin (100 μM) and glibencla-
mide (200 μM), of the CFTR Cl
− channel, glibenclamide
(200 μM), and of the transporter MRP, probenecid (1 mM).
Also, the ATP release was not sensitive to inhibitors of
connexin or pannexin hemichannels, 1-octanol (2 mM) and
carbenoxolone (100 μM), and a blocker of the P2X7
receptor, brilliant blue G (1 μM). Preincubation of the cells
with an inhibitor of vesicular transport, brefeldin A (BFA,
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2+
chelator, BAPTA-AM (5 μM), for 30 min had no
significant effect on the OGD-induced release of ATP
(Fig. 1b).
In order to detect ATP release at the surface of single
astrocytes, we employed a biosensor ATP assay technique
[23]. We first established the calibration curve by recording
the responses of biosensor HEK-P2X2 cells to different
ab
Fig. 2 Cell surface ATP release induced by OGD from single
astrocytes. a Calibration of ATP measurements by the biosensor
technique. Top panel: representative current responses evoked by puff
applications of 1–20 μM ATP in a biosensor HEK-P2X2 cell under
whole-cell clamp. Bottom panel: concentration-response curve of the
ATP-induced currents recorded from biosensor cells. Each data point
represents the mean ± SEM (vertical bar). b Representative current
traces recorded from biosensor cells in close proximity to target
astrocytes after perfusion with standard Ringer solution (top panel)o r
with the OGD solution in the absence (middle panel) or presence
(bottom panel) of 0.1 mg/ml apyrase, which was applied after current
responses appeared. When apyrase was applied from the beginning of
OGD application, no current response was observed in biosensor cells
positioned next to astrocytes (data not shown)
a b
Fig. 1 OGD-induced ATP re-
lease from astrocytes detected
by the luciferin-luciferase assay.
a Time course of ATP release
during incubation with control
standard Ringer solution (open
circles) and with the OGD so-
lution (filled circles). b Pharma-
cological profiles of ATP release
measured 20 min after applica-
tion of OGD solution. Each data
point or column represents the
mean ± SEM (vertical bar).
*Significantly different from the
control OGD value in the
absence of drugs at P<0.05
150 Purinergic Signalling (2008) 4:147–154known concentrations of ATP (Fig. 2a). We then gently put
the biosensor cell close to the surface of a target astrocyte
and recorded the whole-cell current responses from the
biosensor cell. As shown in Fig. 2b (top panel), virtually no
ATP-evoked currents were observed during perfusion of
standard Ringer solution. However, inward current spikes
were consistently recorded upon perfusion with OGD
solution after a lag period of 7.2±1.0 min (n=5) (Fig. 2b:
middle panel). The OGD-induced inward current responses
were eliminated by application of an ATP-hydrolyzing
enzyme, apyrase (Fig. 2b: bottom panel). OGD-induced
responses were never observed in biosensor cells alone
which were positioned remote from target astrocytes. Using
the calibration curve, the local ATP concentration was
estimated to be 3.7±0.1 μM at the surface of single
astrocytes subjected to OGD stress.
From these data, it is concluded that in response to OGD
stress, Gd
3+- and arachidonic acid-sensitive ATP release
ab
c
Fig. 3 OGD-induced single-channel activity of the maxi-anion channel
in cell-attached patches on astrocytes. a Representative current trace
recorded during application of alternating pulses (the protocol shown in
inset above). Note that voltage-dependent inactivation of channel
activity took place shortly after application of step pulses to ± 50 mV.
b Current-voltage (I–V) relationship for unitary events of the maxi-
anion channel. The reversal potential was −4.6±1.9 mV. Each data
point represents the mean ± SEM (vertical bar). c Time course of OGD-
induced activation of the maxi-anion channel. The mean patch currents
recorded at ±50 mV are plotted as a function of time
a b
Fig. 4 Pharmacological profile
of OGD-activated maxi-anion
channel events in inside-out
patches excised from astrocytes.
a Representative current traces
recorded during application of
alternating pulses (the protocol
shown in inset above) in the
absence (control) and presence
of Gd
3+ (50 μM in the pipette),
arachidonic acid (20 μM in the
bath), and phloretin (100 μMi n
the bath). b Effects of Gd
3+,
arachidonic acid, and phloretin
on the OGD-induced single-
channel activity recorded at ±
25 mV. Data are normalized to
the mean currents before appli-
cation of drugs. Each column
represents the mean ± SEM
(vertical bar). *Significantly
different from the control value
at P<0.05
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concentration to a level high enough to stimulate most
types of purinergic receptors.
OGD activates ATP-conductive maxi-anion channels
in astrocytes
The fact that both Gd
3+ and arachidonic acid are potent
blockers of maxi-anion channels in mouse astrocytes [17]
suggests that OGD-induced ATP release involves the
activity of maxi-anion channels. In cell-attached experi-
ments, OGD stress actually induced activation of anion
channels with a large conductance (Fig. 3a), as seen to
occur in a similar manner upon stimulation by hypotonicity
or chemical ischemia in mouse astrocytes [17]. The unitary
I–V relationship for these events exhibited slight outward
rectification, and the mean slope conductance was 427±
23 pS at +60 mV and 262±21 pS at −50 mV (Fig. 3b). In
cell-attached patches, OGD-induced activation of the maxi-
anion channel started with a lag time of several minutes and
reached its peak within 10 min (8.8±1.2 min, n=6), as
shown in Fig. 3c.
The single-channel activity induced by OGD persisted
after excision of the patch (Fig. 4: control). In the inside-out
mode, however, the channel activity was blocked by
extracellular Gd
3+ (50 μM) in backfilled pipettes and by
intracellular (bath) application of 20 μM arachidonic acid
(Fig. 4:G d
3+ and arachidonate). In contrast, phloretin
(100 μM) failed to affect the maxi-anion channel activity
(Fig. 4: phloretin).
In inside-out patches, when the bath solution was
changed from standard Ringer solution to a 100 mM
Na4ATP solution, the reversal potential shifted from 0 mV
to −20.6±0.9 mV (n=6); from this result, a PATP/PCl value
was estimated to be 0.11±0.01 (Fig. 5).
These results indicate that in astrocytes OGD stress
activates a maxi-anion channel which can conduct anionic
forms of ATP and is sensitive to Gd
3+ and arachidonic acid.
Discussion
In the brain, bidirectional communication takes place
between glial cells and neurons. Astrocytes clear synapti-
cally released glutamate from the synaptic cleft, receive
signals from neurons at certain receptors, and release
molecules, called gliotransmitters, that modulate synaptic
transmission, protect neurons from impairment, or repair
neuronal tissues after damage. ATP and glutamate represent
major gliotransmitters. It has been reported that astrocytes
release ATP in response to a number of stimuli, including
receptor activation [5–7], mechanical or osmotic perturba-
tion [8–11], and deprivation of extracellular Ca
2+ [8, 9, 12].
The present study demonstrated that astrocytes also respond
to ischemic stress mimicked by OGD with ATP release
(Figs. 1a and 2b). ATP released from astrocytes has been
shown to regulate glutamatergic synaptic transmission [6, 7,
10], inhibit excitability of retinal neurons [26], activate
microglia [27, 28], modulate some functions of astrocytes
[11], and protect astrocytes themselves from H2O2-
Fig. 5 Representative ramp I–V
records of single-channel events
of the maxi-anion channel pre-
activated by OGD in an inside-
out patch exposed to standard
Ringer solution (chloride) and
one exposed to 100 mM
Na4ATP solution (ATP). The
inward currents recorded in the
ATP-exposed patch represent
ATP
4− currents. The amplitude
of outward currents became
smaller when ATP
4− was present
in the bath, suggesting a block-
ing of currents by ATP
4−,a s
observed in mammary C127
cells [19]
152 Purinergic Signalling (2008) 4:147–154induced cell death [29]. Pathophysiological functions of
ischemia-induced ATP release from astrocytes remain to
be elucidated.
There has been much controversy about the pathway of
nonlytic release of ATP from a variety of cell types [30,
31]. The candidate pathways proposed for astrocytic ATP
release include connexin hemichannels [8], MRP [11],
P2X7 receptors [12], and exocytotic vesicular transport [9].
In the present study, however, OGD-induced ATP release
was shown to be insensitive to blocking agents for
connexin hemichannels (1-octanol, carbenoxolone), MRP
(probenecid), P2X7 receptors (brilliant blue G), and
exocytosis (BFA plus BAPTA-AM) (Fig. 1b). Recently, it
was reported that pannexins form ATP-conductive channels
when expressed in Xenopus oocytes [32]. However, a
possible involvement of the pannexin hemichannel in
OGD-induced ATP release from astrocytes can be ruled
out by the present observation (Fig. 1b) of insensitivity to
carbenoxolone, which is a potent blocker of not only
connexin but also pannexin hemichannels as well [33].
Although VSOR anion channels were shown to be
permeable to ATP at large positive potentials in endothelial
cells [34], potent VSOR blockers (phloretin, glibenclamide)
failed to affect OGD-induced ATP release from astrocytes
in the present study (Fig. 1b). In contrast, Gd
3+ and
arachidonic acid were found to prominently suppress ATP
release from mouse astrocytes subjected to OGD (Fig. 1b).
Our previous study [17] showed that in mouse astrocytes,
maxi-anion channels are activated by chemical ischemia
and are sensitive to both Gd
3+ and arachidonic acid. The
present study demonstrated that maxi-anion channels are
activated by OGD (Fig. 3) and that OGD-activated maxi-
anion channels are sensitive to Gd
3+ and arachidonic acid
(Fig. 4) and can conduct anionic forms of ATP (Fig. 5). On
balance, it appears that the maxi-anion channel serves as a
major pathway for OGD-induced ATP release from mouse
astrocytes in primary culture. Our preliminary study has
shown that in mouse hippocampal slices, astrocytes also
respond to OGD with the activation of maxi-anion channels
(H.-T. Liu, R.Z. Sabirov, Y. Okada, unpublished observa-
tions). Since ischemia-like stress was reported to induce
ATP release from hippocampal slices [13], it is highly
possible that the maxi-anion channel also provides a
pathway for ischemia-induced ATP release from astrocytes
in slice preparations.
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